Stabilization of brain natriuretic peptide (BNP) in blood samples, methods and compositions related thereto

Details for Australian Patent Application No. 2003204649 (hide)

Owner Bayer Corporation

Inventors Bluestein, Barry; Belenky, Alexander

Agent Griffith Hack

Pub. Number AU-A-2003204649

Priority 60/389,991 19.06.02 US

Filing date 12 June 2003

Wipo publication date 15 January 2004

International Classifications

C12N 009/99 Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

26 June 2003 Complete Application Filed

  Priority application(s): 60/389,991 19.06.02 US

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003204649

17 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204650-System and method for developing interactive speech applications

2003204648-High efficiency resonant line